Scientists Find Intriguing Link Between Ozempic and Violent Behavior

Live updates

1. 14d ago

   Rutgers Study Links GLP-1 Medications to Lower Violence Risk

   Researchers at Rutgers University found that GLP-1 medications like Ozempic and Wegovy may reduce violent behavior. These drugs, originally for type 2 diabetes and weight loss, may impact behaviors beyond metabolic health. The study was published in Criminology.

   What's confirmed:

   • GLP-1 receptor agonist medications were originally developed to help people with type 2 diabetes control blood sugar levels.
   • Rutgers researchers studied whether GLP-1 medications such as Ozempic and Wegovy influence violent criminal behavior.
   • The research regarding GLP-1 medications and violence was published in Criminology.

   Still unconfirmed:

   • Rates of GLP-1 use and misuse are high among people with a history of eating disorders.
   • GLP-1 drugs reduce appetite and help people feel full.
   confidence 90%
2. 18d ago

   Rutgers Study Links GLP-1 Drugs to Reduced Violent Behavior

   Research from Rutgers University indicates GLP-1 medications may lower the risk of violent behavior. The study suggests these drugs weaken the connection between impulsivity, alcohol, and violence. Researchers call for further study to understand these behavioral changes.

   What's confirmed:

   • A Rutgers University study found GLP-1 medications are linked to less violent behavior.
   • Current GLP-1 users showed weaker links between impulsivity, alcohol, and violent acts.
   • The medications weakened the impulsivity-violence link by 62%.
   • The medications weakened the alcohol-violence link by 52%.

   Still unconfirmed:

   • GLP-1 medications act as a biological circuit breaker that mimics cognitive behavioral therapy.
   • Weight-loss drugs like Ozempic can act as antidepressants due to changes in the gut microbiome.
   confidence 90%
3. 21d ago

   Rutgers Study Links GLP-1 Drugs to Lower Risk of Violent Behavior

   Research from Rutgers suggests GLP-1 medications like Ozempic and Wegovy may reduce the risk of violent behavior. These drugs primarily treat obesity and type 2 diabetes. The study indicates these medications might alter behavioral patterns.

   What's confirmed:

   • Rutgers research suggests Ozempic may be linked to changes in behaviors.
   • GLP-1 receptor agonists such as Ozempic and Wegovy are used to treat obesity and type 2 diabetes.

   Still unconfirmed:

   • GLP-1 drugs weaken the link between impulsive tendencies and action.
   confidence 90%
4. 22d ago

   GLP-1 Medications Linked to Reduced Violent Behavior

   Rutgers researchers found that GLP-1 drugs like Ozempic and Wegovy may lower the risk of violent behavior. The study suggests these medications weaken the link between impulsive tendencies and action. These findings indicate potential mental health benefits beyond metabolic health.

   What's confirmed:

   • A Rutgers study suggests GLP-1 drugs such as Ozempic and Wegovy may weaken the link between impulsive tendencies and violent behavior.
   • The study was published in Criminology and examined how GLP-1 receptor agonist medications influence violent criminal behavior among adults by moderating alcohol intake and impulsivity.
   • GLP-1 medications are associated with lower rates of cocaine, nicotine, opioid, and alcohol use.

   Still unconfirmed:

   • Inmates in Scotland have been given the drug to reduce violent crime.
   • An Arizona treatment center is using weight loss medications in addiction recovery.
   • The mechanisms that dampen food cravings might also affect the tendency for violent behavior.
   confidence 90%